M. Huiban

Suggest Changes
  • Citations Per Year
Learn More
TPS107 Background: Patients with HER2+ breast cancer tend to develop visceral metastases. Several anti-cancer agents including trastuzumab are not believed to readily cross the blood-brain barrier(More)
  • 1